WELDING GmbH & Co. KG, through its business unit PHARMA FDF, announces its first European marketing authorizations for Tafamidis 61 mg soft capsules
WELDING GmbH & Co. KG announces an important regulatory milestone in Europe. Following the successful closure of the Dec…